Vitals CEO Mitch Rothschild on how they enable consumers to make informed decisions about the cost and quality of their medical care
Theranos founder Elizabeth Holmes on revolutionizing the way we use blood tests.
Would you mind if a dozen total strangers sat in on your next doctor visit?While shared medical appointments may seem like a radical departure from traditional one-o...
FBN’s Nicole Petallides breaks down the day in the markets.
FBN’s Liz MacDonald weighs in on AOL CEO Tim Armstrong’s controversial comments and 401(k) plans.
Strategic Resource Group managing director Burt Flickinger and FBN's Liz MacDonald on retail sales.
January was a tough end to a tough holiday season for U.S. retailers.Shoppers last month continued to pinch their pennies, seeking out bargains and paying fewer visi...
MaxFunds.com’s Jonas Max Ferris and Starfire Cigs CEO Stephan Karian on CVS Pharmacy’s decision to stop selling tobacco products.
FBN’s David Asman on CVS Caremark’s plans to stop selling all tobacco products.
Armed with no research, lawmakers take a stand
The traditional cigarette market took a big hit on Wednesday after CVS (NYSE:CVS) said tobacco no longer has a place in settings promoting healthy living.Lots of peo...
FBN's Jeff Flock on the impact of CVS's decision to pull tobacco products off store shelves on stock prices.
Macro Trend Investor editor Charles Sizemore on CVS Caremark, General Motors and Microsoft.
Sales for many U.S. retailers rose in February, as shoppers ventured out later in the month after a dismal start when ice, cold and snow kept many of them at home.Co...
Walgreen (NYSE:WAG) reported a 5% improvement in a key revenue metric on Wednesday as pharmacy sales grew despite the negative impacts of a harsh winter weather and ...
RadioShack (NYSE:RSH) said Wednesday its board approved retention bonuses of up to $1.49 million combined for top executives, aiming to keep its leadership in place ...
Why certain items cost more at the drug store
Small Business Center: How to pass the ‘business card test,’ controversial Arizona bill upsetting companies, medical cost transparency for the masses, and will banks lend to marijuana merchants?
Big chains receive lowest satisfaction scores
Manhattan Institute’s Avik Roy on the impact of ObamaCare on businesses.